These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2469889)

  • 1. Age-related effects of angiotensin converting enzyme inhibitors.
    Breckenridge A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S100-4. PubMed ID: 2469889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Converting-enzyme inhibitors in the treatment of elderly hypertension patients].
    Amery A; Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; van Hoof R
    Wien Med Wochenschr; 1990 Jan; 140(1-2):30-4. PubMed ID: 2408248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related effects of converting enzyme inhibitors: a commentary.
    Ball SG
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S105-8. PubMed ID: 2469890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE-inhibitors in the treatment of elderly hypertensives.
    M'Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; Van Hoof R; Amery A
    Geriatrics; 1987 Jun; 42(6):45-9. PubMed ID: 3034739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension: a review with emphasis on therapeutics with ACE inhibitors.
    Preuss HG; Gondal JA; Burris JF
    Md Med J; 1993 Jun; 42(6):557-64. PubMed ID: 8377628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.
    Ajayi AA; Reid JL
    Int J Clin Pharmacol Res; 1988; 8(5):327-33. PubMed ID: 2852643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors: are they all alike?
    Case DB
    J Clin Hypertens; 1987 Sep; 3(3):243-56. PubMed ID: 2822859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.